KYMR Insider Trading

Kymera Therapeutics, Inc. (KYMR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $10.89B, listed on NASDAQ, employing roughly 273 people, carrying a beta of 2.03 to the broader market. Kymera Therapeutics, Inc. Led by Nello Mainolfi, public since 2020-08-21.

In the last 12 months, Kymera Therapeutics, Inc. insiders made 2 buy transactions and 274 sale transactions.

DateNameTypeSharesPriceValue
Oct 1, 2026Mainolfi NelloM-Exempt30,000$2.08$62.4K
Oct 1, 2026Mainolfi NelloS-Sale3,525$111.44$392.8K
Oct 1, 2026Mainolfi NelloS-Sale5,506$112.42$619.0K
Oct 1, 2026Mainolfi NelloS-Sale4,876$113.24$552.2K
Oct 1, 2026Mainolfi NelloS-Sale7,601$114.43$869.8K
Oct 1, 2026Mainolfi NelloS-Sale8,230$115.40$949.7K
Oct 1, 2026Mainolfi NelloS-Sale262$116.12$30.4K
Oct 1, 2026Mainolfi NelloM-Exempt30,000$2.08$62.4K
Sep 4, 2026Adams BrianS-Sale1,209$115.55$139.7K
Sep 4, 2026Adams BrianS-Sale3,025$116.81$353.4K

KYMR Insider Activity by Quarter

Reported Form 4 and Form 5 lines under KYMR's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Aug 22, 2024, and a quarter counts only when every filing for it was read. Last refreshed Oct 31, 2026.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)0N/A6$3.4M2
Q3 20260N/A10$16.3M7
Q2 20260N/A182$387.7M51
Q1 20260N/A47$25.9M33
Q4 20252$172.5M38$46.0M28
Q3 20250N/A2$5.4M7
Q2 20255$42.8M7$2.9M23
Q1 20250N/A9$630.0K15
Q4 20240N/A1$122.5K2

KYMR Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 275 institutions reported holding 97,007,020 KYMR shares, valued at $11.09B as reported, 105.2% of its market cap (market cap of Jun 26, 2026). That is +19 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 43 opened a position, 23 closed one, 97 added and 83 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
FMR LLC12,349,256$1.42B+649,306
BAKER BROS. ADVISORS LP8,657,242$992.7MUnchanged
Avoro Capital Advisors LLC7,474,747$857.1MUnchanged
PRICE T ROWE ASSOCIATES INC /MD/7,112,980$815.6M+1,052,133
T. Rowe Price Investment Management, Inc.6,257,261$717.5M+792,264
BlackRock, Inc.5,538,210$635.1M+477,334
BVF INC/IL3,872,052$444.0M-1,630,658
WELLINGTON MANAGEMENT GROUP LLP3,675,028$421.4M-214,659
VANGUARD PORTFOLIO MANAGEMENT LLC2,992,193$343.1M+118,137
Siren, L.L.C.2,935,830$336.7M-251,000

By Quarter

QuarterInstitutionsSharesValue
Q2 202627597,007,020$11.09B
Q1 202625696,291,501$8.01B
Q4 202525589,970,097$7.00B
Q3 202521081,057,450$4.59B
Q2 202521078,957,382$3.45B
Q1 202517272,847,341$2.00B
Q4 202418071,721,929$2.89B
Q3 202417569,100,863$3.27B
Q2 202415768,180,923$2.04B

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding KYMR

FundWeight of KYMRShares (as reported)Value (as reported)Source updated
VTI Vanguard Morningstar Total Stock Market ETF0.01%2,100,268$234.8MNov 12, 2026
IWM iShares Russell 2000 ETF0.28%1,621,822$218.7MNov 12, 2026
VB Vanguard Morningstar Small-Cap ETF0.09%1,496,561$167.3MNov 12, 2026
XBI State Street SPDR S&P Biotech ETF1.41%1,129,969$152.4MNov 12, 2026
VBK Vanguard Morningstar Small-Cap Growth ETF0.21%833,887$93.2MNov 12, 2026
VXF Vanguard Extended Market ETF0.10%825,060$92.2MNov 12, 2026
IBB iShares Biotechnology ETF0.68%574,960$77.5MNov 12, 2026
IWO iShares Russell 2000 Growth ETF0.46%488,149$65.8MNov 12, 2026
SCHA Schwab U.S. Small-Cap ETF0.23%390,769$49.7MNov 13, 2026
VTWO Vanguard Russell 2000 ETF0.23%364,080$40.7MNov 12, 2026
DFAS Dimensional - US Small Cap ETF0.10%250,499$33.8MNov 13, 2026
SCHM Schwab U.S. Mid-Cap ETF0.19%223,213$28.4MNov 13, 2026
TCAF T. Rowe Capital Appreciation Equity ETF0.27%165,776$22.4MNov 13, 2026
DFAC Dimensional - US Core Equity 2 ETF0.02%154,893$20.9MNov 13, 2026
VHT Vanguard Health Care ETF0.08%157,096$17.6MNov 12, 2026

From each fund's latest holdings file on record that shows KYMR's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as KYMR's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for KYMR reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is KYMR's share of that fund.

How to Read KYMR Insider Activity

Net insider sentiment skews to the sell side over the trailing twelve months: 274 sales versus 2 buys. Insider sales carry less informational weight than buys because they are often driven by liquidity, tax planning, or pre-scheduled Rule 10b5-1 trading plans rather than negative information. The transaction type alone does not say whether a sale was made on the open market or privately, or under a 10b5-1 plan; the filing's plan checkbox and footnotes do. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked KYMR insider trading questions

How active are KYMR insiders right now?
Over the trailing twelve months, Kymera Therapeutics, Inc. (KYMR) insiders made 2 buy transactions and 274 sale transactions. Net insider sentiment over the trailing twelve months tilts to the sell side (274 sales vs 2 buys). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are KYMR insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do KYMR insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.